These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36409909)

  • 21. Genetically modified bacteriophages.
    Sagona AP; Grigonyte AM; MacDonald PR; Jaramillo A
    Integr Biol (Camb); 2016 Apr; 8(4):465-74. PubMed ID: 26906932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing phage therapy through synthetic biology and genome engineering.
    Lenneman BR; Fernbach J; Loessner MJ; Lu TK; Kilcher S
    Curr Opin Biotechnol; 2021 Apr; 68():151-159. PubMed ID: 33310655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.
    Lewis JM; Williams J; Sagona AP
    Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.
    Faltus T
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage-based vaccines.
    Bao Q; Li X; Han G; Zhu Y; Mao C; Yang M
    Adv Drug Deliv Rev; 2019 May; 145():40-56. PubMed ID: 30594492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
    Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
    Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-Genus "Boot-Up" of Synthetic Bacteriophage in Staphylococcus aureus by Using a New and Efficient DNA Transformation Method.
    Assad-Garcia N; D'Souza R; Buzzeo R; Tripathi A; Oldfield LM; Vashee S; Fouts DE
    Appl Environ Microbiol; 2022 Feb; 88(3):e0148621. PubMed ID: 34818102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myriad applications of bacteriophages beyond phage therapy.
    García-Cruz JC; Huelgas-Méndez D; Jiménez-Zúñiga JS; Rebollar-Juárez X; Hernández-Garnica M; Fernández-Presas AM; Husain FM; Alenazy R; Alqasmi M; Albalawi T; Alam P; García-Contreras R
    PeerJ; 2023; 11():e15272. PubMed ID: 37101788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilm control with natural and genetically-modified phages.
    Motlagh AM; Bhattacharjee AS; Goel R
    World J Microbiol Biotechnol; 2016 Apr; 32(4):67. PubMed ID: 26931607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies.
    Liyanagedera SBW; Williams J; Wheatley JP; Biketova AY; Hasan M; Sagona AP; Purdy KJ; Puxty RJ; Feher T; Kulkarni V
    ACS Synth Biol; 2022 Oct; 11(10):3330-3342. PubMed ID: 36194543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage therapy--constraints and possibilities.
    Nilsson AS
    Ups J Med Sci; 2014 May; 119(2):192-8. PubMed ID: 24678769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.